Literature DB >> 19731624

Bone formation versus bone resorption in ankylosing spondylitis.

Georg Schett1.   

Abstract

Ankylosing spondylitis (AS) and other forms of seronegative spondylarthritis (SpA) are characterized by two major processes in joints-the first is chronic inflammation and the second is progressive ankylosis. Both features go hand-in-hand and determine the clinical picture of disease, which is joint pain, progressive stiffness and, in case ofperipheral joint involvement also joint swelling. The interplay between inflammation and ankylosis is best illustrated in AS, where chronic inflammation of the spine leads to progressive stiffness, reduced spinal mobility and kyphosis. AS may thus be considered as a synthesis of inflammatory disease and bone disease.

Entities:  

Mesh:

Year:  2009        PMID: 19731624     DOI: 10.1007/978-1-4419-0298-6_8

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  19 in total

1.  Ankylosing spondylitis is characterized by an increased turnover of several different metalloproteinase-derived collagen species: a cross-sectional study.

Authors:  Anne C Bay-Jensen; Diana J Leeming; Arndt Kleyer; Sanne S Veidal; Georg Schett; Morten A Karsdal
Journal:  Rheumatol Int       Date:  2011-11-16       Impact factor: 2.631

Review 2.  Wnt/β-catenin signaling plays a key role in the development of spondyloarthritis.

Authors:  Wanqing Xie; Lijiang Zhou; Shan Li; Tianqian Hui; Di Chen
Journal:  Ann N Y Acad Sci       Date:  2015-12-02       Impact factor: 5.691

3.  Role of protein phosphatase magnesium-dependent 1A and anti-protein phosphatase magnesium-dependent 1A autoantibodies in ankylosing spondylitis.

Authors:  Yong-Gil Kim; Dong Hyun Sohn; Xiaoyan Zhao; Jeremy Sokolove; Tamsin M Lindstrom; Bin Yoo; Chang-Keun Lee; John D Reveille; Joel D Taurog; William H Robinson
Journal:  Arthritis Rheumatol       Date:  2014-10       Impact factor: 10.995

4.  Bushen Qiangji Granule () medicated serum inhibits osteogenic differentiation of fibroblasts in ankylosing spondylitis by inhibiting the BMP/Smads signal pathway in vitro.

Authors:  Hong-Xiao Liu; Nan Jiang; Hui-Ying Liang; Ying-Yan Zhou; Xing-Hua Feng; Xiao-Yan Feng; He-Qiu Zhang; Zhi-Kui Wu; Quan Jiang; Jiao Fu; Xiao-Juan Ma; Peng Chen
Journal:  Chin J Integr Med       Date:  2016-10-26       Impact factor: 1.978

5.  MMP-2 silencing reduces the osteogenic transformation of fibroblasts by inhibiting the activation of the BMP/Smad pathway in ankylosing spondylitis.

Authors:  Bo Yuan; Zhiming Wu
Journal:  Oncol Lett       Date:  2017-12-29       Impact factor: 2.967

6.  Serum prolidase level in ankylosing spondylitis: low serum levels as a new potential gold standard biomarker for disease activity.

Authors:  Sevgi Baspinar; Mehmet Kırnap; Osman Baspınar; Oguzhan Sıtkı Dizdar; Derya Kocer
Journal:  Rheumatol Int       Date:  2016-07-21       Impact factor: 2.631

7.  Biomarkers and cytokines of bone turnover: extensive evaluation in a cohort of patients with ankylosing spondylitis.

Authors:  Ali Taylan; Ismail Sari; Baris Akinci; Safak Bilge; Didem Kozaci; Servet Akar; Ayfer Colak; Hulya Yalcin; Necati Gunay; Nurullah Akkoc
Journal:  BMC Musculoskelet Disord       Date:  2012-10-02       Impact factor: 2.362

8.  Whole blood transcriptional profiling in ankylosing spondylitis identifies novel candidate genes that might contribute to the inflammatory and tissue-destructive disease aspects.

Authors:  Fernando M Pimentel-Santos; Dário Ligeiro; Mafalda Matos; Ana F Mourão; José Costa; Helena Santos; Anabela Barcelos; Fátima Godinho; Patricia Pinto; Margarida Cruz; João E Fonseca; Henrique Guedes-Pinto; Jaime C Branco; Matthew A Brown; Gethin P Thomas
Journal:  Arthritis Res Ther       Date:  2011-04-07       Impact factor: 5.156

9.  Transgenic mice over-expressing carbonic anhydrase I showed aggravated joint inflammation and tissue destruction.

Authors:  Yabing Zheng; Lin Wang; Wei Zhang; Hengwei Xu; Xiaotian Chang
Journal:  BMC Musculoskelet Disord       Date:  2012-12-20       Impact factor: 2.362

10.  Carbonic anhydrase I (CA1) is involved in the process of bone formation and is susceptible to ankylosing spondylitis.

Authors:  Xiaotian Chang; Yabing Zheng; Qingrui Yang; Lin Wang; Jihong Pan; Yifang Xia; Xinfeng Yan; Jinxiang Han
Journal:  Arthritis Res Ther       Date:  2012-07-27       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.